Delivery Order SPE2DB20D3103-SPE2DB25FN7D1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,539.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylergonovine 0.2 mg tablets in packages of 12. The contract, with an ultimate completion date of September 19, 2025, represents a non-competitive, non-set-aside procurement delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL in vial form, with a ceiling value of $1,497.98. This firm fixed-price delivery order was competitively awarded without set-aside designations and is scheduled for completion by September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Methylergonovine is an ergot alkaloid...
- The Defense Logistics Agency awarded a delivery order valued at $1,160.58 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 7, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and gynecological applications to prevent or...
- This delivery order, awarded September 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of methylergonovine 0.2 mg tablets in quantities of 28 units. The contract is valued at $7,605.24 with a firm fixed price structure and no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylergonovine 0.2 mg tablets in unit dose packages of 20, with a ceiling value of $11,136.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a $1,602.15 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract procures a pharmaceutical product used in obstetric care to prevent and treat postpartum...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN7D1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $37,979.91 to AmerisourceBergen Drug Corp for the supply of methylergonovine 0.2 mg tablets in unit dose packaging of 20 tablets. This competitive award, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's established pharmaceutical distribution infrastructure and federal contracting capabilities. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen utilizes this prime vendor vehicle to supply medications and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. The methylergonovine supply under this delivery order supports federal medical procurement requirements for this critical obstetric medication, demonstrating the contractor's role in ensuring pharmaceutical availability for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.0k | 5/6/25 |